The total return over the past 12 months is +38.65% vs. +16.94% for the S&P 500. So far it's up +9.58% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +38.65% | +88.42% | +61.74% | N/A | N/A | N/A |
| Total Return CAGR | +38.65% | +88.42% | +61.74% | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Trevi Therapeutics, Inc. (TRVI)
| Year | Start price | End price | TRVI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $12.52 | $13.72 | +9.58% | +14.51% | (4.93%) |
| 2025 | $4.12 | $12.52 | +203.88% | +17.72% | +186.16% |
| 2024 | $1.34 | $4.12 | +207.46% | +24.89% | +182.57% |
| 2023 | $1.93 | $1.34 | (30.57%) | +26.19% | (56.76%) |
| 2022 | $0.78 | $1.93 | +146.74% | (18.17%) | +164.91% |
| 2021 | $2.42 | $0.78 | (67.68%) | +28.74% | (96.42%) |
| 2020 | $3.75 | $2.42 | (35.47%) | +18.37% | (53.84%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
